Suppr超能文献

芳香族氨基酸传感器 GPR142 通过平衡调节胰腺和肠道激素来控制代谢。

The aromatic amino acid sensor GPR142 controls metabolism through balanced regulation of pancreatic and gut hormones.

机构信息

Section for Metabolic Receptology, Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark; Laboratory for Molecular Pharmacology, Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Merck Research Laboratories, 2015 Galloping Hills Road, Kenilworth, NJ, USA.

出版信息

Mol Metab. 2019 Jan;19:49-64. doi: 10.1016/j.molmet.2018.10.012. Epub 2018 Nov 5.

Abstract

OBJECTIVES

GPR142, which is highly expressed in pancreatic islets, has recently been deorphanized as a receptor for aromatic amino acids; however, its physiological role and pharmacological potential is unclear.

METHODS AND RESULTS

We find that GPR142 is expressed not only in β- but also in α-cells of the islets as well as in enteroendocrine cells, and we confirm that GPR142 is a highly selective sensor of essential aromatic amino acids, in particular Trp and oligopeptides with N-terminal Trp. GPR142 knock-out mice displayed a very limited metabolic phenotype but demonstrated that L-Trp induced secretion of pancreatic and gut hormones is mediated through GPR142 but that the receptor is not required for protein-induced hormone secretion. A synthetic GPR142 agonist stimulated insulin and glucagon as well as GIP, CCK, and GLP-1 secretion. In particular, GIP secretion was sensitive to oral administration of the GPR142 agonist an effect which in contrast to the other hormones was blocked by protein load. Oral administration of the GPR142 agonist increased [H]-2-deoxyglucose uptake in muscle and fat depots mediated through insulin action while it lowered liver glycogen conceivably mediated through glucagon, and, consequently, it did not lower total blood glucose. Nevertheless, acute administration of the GPR142 agonist strongly improved oral glucose tolerance in both lean and obese mice as well as Zucker fatty rat. Six weeks in-feed chronic treatment with the GPR142 agonist did not affect body weight in DIO mice, but increased energy expenditure and carbohydrate utilization, lowered basal glucose, and improved insulin sensitivity.

CONCLUSIONS

GPR142 functions as a sensor of aromatic amino acids, controlling GIP but also CCK and GLP-1 as well as insulin and glucagon in the pancreas. GPR142 agonists could have novel interesting potential in modifying metabolism through a balanced action of gut hormones as well as both insulin and glucagon.

摘要

目的

GPR142 在胰岛中高度表达,最近被鉴定为芳香族氨基酸的受体;然而,其生理作用和药理学潜力尚不清楚。

方法和结果

我们发现 GPR142 不仅在胰岛的β细胞中表达,而且在α细胞和肠内分泌细胞中表达,并且我们证实 GPR142 是必需芳香族氨基酸,特别是色氨酸和具有 N 端色氨酸的寡肽的高度选择性传感器。GPR142 敲除小鼠表现出非常有限的代谢表型,但证明 L-色氨酸诱导的胰腺和肠道激素分泌是通过 GPR142 介导的,但该受体不是蛋白质诱导激素分泌所必需的。一种合成的 GPR142 激动剂刺激胰岛素和胰高血糖素以及 GIP、CCK 和 GLP-1 的分泌。特别是,GIP 分泌对 GPR142 激动剂的口服给药敏感,与其他激素不同,这种作用被蛋白质负荷阻断。GPR142 激动剂的口服给药通过胰岛素作用增加肌肉和脂肪组织中的 [H]-2-脱氧葡萄糖摄取,而降低肝糖原,这可以通过胰高血糖素介导,因此不会降低总血糖。然而,GPR142 激动剂的急性给药在瘦鼠和肥胖鼠以及 Zucker 肥胖大鼠中均显著改善了口服葡萄糖耐量。在 DIO 小鼠中,6 周的饲料中慢性 GPR142 激动剂治疗不会影响体重,但增加了能量消耗和碳水化合物利用,降低了基础血糖,并改善了胰岛素敏感性。

结论

GPR142 作为芳香族氨基酸的传感器发挥作用,控制 GIP 以及 CCK 和 GLP-1 以及胰岛素和胰高血糖素在胰腺中的作用。GPR142 激动剂可能通过肠道激素以及胰岛素和胰高血糖素的平衡作用,在调节代谢方面具有新的有趣的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cec/6323244/d54023288ce2/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验